Spyre Therapeutics Inc. (SYRE) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

SYRE ratio: 41%

100%

SYRE beat 14 of 34 last estimates

Date of next report: Nov 14, 2024

Estimate for Q3 24: $-0.93

Implied change from Q2 24: +8.14%

Implied change from Q3 23: -72.89%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q2 24	Aug 7, 2024	$-0.86 / $-0.9	$0.04 / 4.44%
Q1 24	May 9, 2024	$-1.2 / $-0.9	$-0.3 / -33.33%
Q4 23	Feb 29, 2024	$-2.28 / $-0.48	$-1.8 / -375%
Q3 23	Nov 9, 2023	$-3.43 / $-0.44	$-2.99 / -679.55%
Q2 23	Aug 11, 2023	$-41.5 / $-4.5	$-37 / -822.22%
Q1 23	May 11, 2023	$-5 / $-4.75	$-0.25 / -5.26%
Q4 22	Mar 2, 2023	$-4.5 / $-5	$0.5 / 10%
Q3 22	Nov 3, 2022	$-4.75 / $-6	$1.25 / 20.83%

Data Vendor: Xignite Logo